Cash Ratio Analysis of NeuBase Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointCash Ratio of NBSE
Sep-225.56Very Good Cash Ratio | Sep-2112.61Excellent Cash Ratio | Growth-55.94% |
Cash Ratio Analysis of NeuBase Therapeutics Inc
| Cash Ratio of NeuBase Therapeutics Inc with value of 5.56 indicates that a company has generated more cash in a period than what is needed to pay off its current liabilities. |
| Cash Ratio of NBSE drastically fell by -55.94 % this year. |
| Cash Ratio with value of 12.61 was highest in Year Sep-21 in last Five Years. |
| Cash Ratio with value of 4.12 was lowest in Year Sep-19 in last Five Years. |
| Latest Cash Ratio with value of 5.56 is lower than Average Cash Ratio of 7.54 in last five years. |
Other Cash Ratio Related Info of NBSE that may interest you.
NeuBase Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| NBSE | 0.378 | 0.3905 | 3.20 % | Biotechnology |
Defination of Cash Ratio
The Cash Ratio measures the liquidity position of the company. This metric indicates how much the company can cover its current liabilities by its cash and cash equivalents. more ..
Cash Ratio Related Ratios
| CurrentRatio | QuickRatio | DebtToEquityRatio |
Tsr Stability Index
| Low Stability Stock | |
FY - Historical Cash Ratio of NeuBase Therapeutics Inc
| Period | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 |
|---|---|---|---|---|---|---|---|
| Cash Ratio | 5.56 | 12.61 | 10.26 | 4.12 | 5.17 | 2.59 | 2.80 |
| Change | -55.94 % | 22.91 % | 148.90 % | -20.31 % | 99.38 % | -7.32 % | -62.15 % |
FY Chart of Cash Ratio of NeuBase Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)